News Column

BRIEF: Hawaii Biotech gets $1.1 million grant for anthrax research

February 5, 2014

The Honolulu Star-Advertiser

Feb. 05--Hawaii Biotech Inc. has been awarded a $1.1 million federal grant to continue its work into the development of anthrax anti-toxin drugs.

The initial round of funding from the National Institute of Allergy and Infectious Diseases is part of a five-year grant totalling $7.4 million. The Institute is part of the National Institutes of Health.

"Research and development of vaccines and treatments to protect against infectious diseases will help keep our families and communities healthy and safe," said U.S. Sen. Brian Schatz.

"Hawaii Biotech is doing important work to find vaccines for some of the biggest global health threats, like anthrax, and this grant will help give them the resources they need. Achieving this competitive grant highlights Hawaii's continued growth in the high-level research and development community."

Hawaii Biotech is a privately held biotechnology company focused on the development of prophylactic vaccines for established and emerging infectious diseases and anti-toxin drugs for biological threats.


(c)2014 The Honolulu Star-Advertiser

Visit The Honolulu Star-Advertiser at

Distributed by MCT Information Services

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Honolulu Star-Advertiser (HI)

Story Tools